Conference abstract · 12 Nov 2013
Conference abstractPublished 12 Nov 2013
GMP in formulation development
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
GMP in formulation development: The formulation process of a cosmetic product is one of the critical steps in developing a new product. GMP during the development procedure has been a rather ambiguous topic in the cosmetics industry. Even though regulatory guidelines are critical elements towards formulation development, there is no strict regulation about GMP while developing a cosmetic product. The global presence of a brand and corporate values and identity are the driving forces for a company to follow GLP/GMP while developing a new cosmetic. The philosophy and the positioning of a company in the frame of GMP during the development process involve many different aspects. It may start from the raw materials selection that will be used in the final formula, to GMP followed during the trial production of the cosmetic. In particular, the main topics that should be observed during the development of the formula include: Raw Materials (approved suppliers, specifications, test methods, manufacturing procedures, storage conditions, certificates of conformance, etc.), the stability testing of the lab batches (test protocols, deviation of the measurements, evaluation of the results), the compatibility testing in terms of different packaging materials, microbiology testing, the safety and the efficacy tests (approved external partners, standard procedures followed, deviations from the procedures, evaluation of the results, documentation), the pilot and trial production (manufacturing process, validations, cleaning and sanitization, filling). By presenting these points, this review aims to highlight how GMP interferes with the development process of a new cosmetic product, the impact of the positioning of the company in the success of the final product, as well as future trends and challenges in this field
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 26 Oct 2015
Effective GMP audits for APIs and formulation in pharma companies
Conference abstract · 26 Oct 2015
Effective GMP AUDITS for APIs and Formulation Pharma Companies
Conference abstract · 21 Oct 2013
Sourcing generic formulations and OTC drugs from Indian pharmaceutical manufacturers: A GMP fiasco waiting to happen?
Research article · 4 Jul 2026
A NEW RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF ENSITRELVIR IN ITS PURE AND FORMULATION
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chryssoula Stamatogianni”

